Latest filing published 02 Nov 2016 for Emmaus Life Sciences, Inc..
Insider track record
No signal scores available.
Robert J. Follman: trading record in brief
Robert J. Follman is a declared insider of Emmaus Life Sciences, Inc., with filings sourced from SEC (Form 4). We count 9 filings; the first trade dates from 14 June 2013 and the latest from 1 November 2016.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 2 November 2016: a share grant, in Emmaus Life Sciences, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert J. Follman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common StockSEC:0001615774-16-007979:0
- 114,074 shares@ US$5.00Common StockSEC:0001615774-16-007357:0
- 250,000 shares0Common StockSEC:0001615774-16-004872:0
- 400,000 shares@ US$0.25Common StockSEC:0001144204-14-010109:0
- 400,000 shares@ US$0.25Common StockSEC:0001144204-14-003316:0
- 400,000 shares@ US$0.25Common StockSEC:0001144204-13-050450:0
- 400,000 shares@ US$0.25Common StockSEC:0001144204-13-046911:0
- 4,491,310 shares@ US$0.0472Common StockSEC:0001144204-13-035493:0
8 of 8 declarations